Daiichi Sankyo Europe GmbH

Breast cancer is the most common cancer globally, and by 2040 the incidence of breast cancer is predicted to be more than 3 million per year. The Lancet Breast Cancer Commission has reported key evidence and data in breast cancer research for several years, with a particular focus on spotlighting the experiences of people living with breast cancer that are more likely to experience inequity in their cancer care. A brand-new 2024 report from the Commission highlights the significant inequities experienced by those living with breast cancer today. These disparities – primarily related to physical symptoms, emotional impact, and financial burden - are often hidden and inadequately addressed. To tackle these issues, the report provides an evidence-based road map that calls for changes that ensure no one is left behind. To see a breakdown of the roadmap for better breast cancer care and to find out more, follow the link here 👉 https://lnkd.in/dECJrCEe #LancetCommission #BreastCancer #MetastaticBreastCancer

🚀 Exciting News from Daiichi Sankyo Europe in Pfaffenhofen! 🚀 We are thrilled to announce that Pfaffenhofen will soon have its very own Daiichi-Sankyo-Straße! 🌟 The Pfaffenhofen town council unanimously decided to honor the importance of our company in the region by naming a new street that runs between Luitpoldstraße and Dieselstraße, right through our factory premises, as Daiichi-Sankyo-Straße. This milestone reflects the rich history of our site, which began as a branch of Luitpoldwerke in 1944, transitioned to the Japanese pharmaceutical company Sankyo in 1990, and became part of the Daiichi Sankyo Group in 2006. #DaiichiSankyo #Pfaffenhofen #Innovation

More than four out of five #CardiovascularDisease (CVD) deaths are due to heart attacks and strokes, and one third of these deaths occur prematurely in people under 70 years old of age. With the general population ageing and the rising prevalence of multimorbid cardiovascular conditions, it’s important that we start to re-think of how we deliver #CardiovascularCare and tailor it to people’s needs 🤗 This is why we are also interested in attending European Society of Cardiology at the end of this month, where we will delve into “Personalised Cardiovascular Care”. #DaiichiSankyoEurope #ESCCongress

At #DaiichiSankyoEurope, we are committed to transforming patients’ lives and supporting their needs beyond medication. In oncology, nurses are essential in ensuring that someone living with cancer gets the care they need, including crucial emotional support. Given the critical role that they play, how they communicate with patients is incredibly important. Through research and discussions with nurses, we identified three areas where we can further support them to communicate effectively 👇 #CancerCare #PatientCentricity

At #DaiiichiSankyoEurope, we champion the inclusion of patient experiences and opinions during the decision-making process in healthcare. The Office of Health Economics (OHE) recently published a white paper; “Incorporating the Patient Voice in Health Technology Assessment”, commissioned and funded by Daiichi Sankyo. The paper highlights the value of including the patient perspective when making key decisions around new health technology. With input from colleagues from Daiichi Sankyo, the research identifies the ways patient evidence data can bring valuable insight to the decision-making process. Discover the three key benefits of using patient input in the snippets from the paper below 👇 Read the full paper at the link here: https://lnkd.in/grKcyGY7

Our Pharma Jobs Explained series is back, where we spotlight less well-known roles in the pharmaceutical industry, and how they contribute to the overall success at #DaiichiSankyoEurope! While you might not have heard much about Value, Access & Pricing before, those in this position are key to ensuring more affordable access to treatments for everyone. This is crucial in driving Daiichi Sankyo’s mission and vision to provide solutions that truly make a difference to those who need them most. Elena Kaiser, Senior Manager Operational Excellence & Capabilities Global Oncology Value, Access & Pricing at Daiichi Sankyo Europe, walked us through her key responsibilities, and the ways her role shapes operational excellence across the company. Read below to find out more from Elena 👇 #IndustryExplained #RolesInPharma 

This year’s edition of the European Society of Cardiology is just around the corner, and we couldn’t be more excited to attend. Attending this congress has always been an opportunity for us to meet leading cardiology experts to discuss advances in the cardiovascular field, ground-breaking research, collaborative initiatives and patient care 🤝 The theme of this year’s congress is ‘Personalising Cardiovascular Care’ and at #DaiichiSankyoEurope, we are interested in learning more about the importance of tailoring #CardiovascularCare to reflect the unique needs of people living with certain cardiovascular conditions. #ESCCongress

Today is #WorldLungCancerDay, and as #LungCancer remains one of the leading causes of cancer-related deaths worldwide, the need for improved diagnostic approaches is significant. Some key risk factors for developing lung cancer are: ✔️Smoking cigarettes – cigarette smoking is linked to approximately 85% of lung cancer cases ✔️Family history of lung cancer ✔️Radon gas exposure ✔️Certain gene mutation An emerging solution to the rising number of lung cancer diagnoses globally is the use of artificial intelligence (AI) in treatments, and in recent years, interest has been sparked in its potential role in screening and treating lung cancer. Read more below to discover ways AI can support healthcare 👇 #DaiichiSankyoEurope #AI

Living an active lifestyle has both physical and mental benefits. When we engage in moderate to vigorous physical activities, like cycling, we are not only exercising our bodies, but we are also improving our overall #CardiovascularHealth. Regular physical activity strengthens your heart muscle and improves your heart’s ability to pump blood to your lungs and throughout your body. As a result, more blood flows to your muscles and oxygen levels in your blood rise. As tomorrow is #CycleToWorkDay, we want to encourage everyone to hop on their bikes and stay active to improve your #HeartHealth! 🚲 #DaiichiSankyoEurope

At #DaiichiSankyo we are dedicated to investing in our employees, and to building a culture where everyone has the opportunity to learn and grow from the very beginning of their journey. Our graduate program is an extensive opportunity that provides new graduates the chance to gain experience in many areas of the business and exercise a diverse range of skills. These valuable experiences provide a strong basis for participants’ future careers, seeing them go on to contribute to the pursuit of excellence in healthcare and beyond. Hear more from recent graduates who took part in and what they enjoyed most below! We are also excited to announce two open positions in our Corporate Graduate Trainee Program. Join our team and kickstart your career with great growth and development prospects here 👉 https://rb.gy/0wmefx